NARCAN Nasal Spray

View All

Opioid-Induced Respiratory Depression Market Outlook
Opioid-Induced Respiratory Depression: Unveiling the Silent Threat

In recent years, the misuse and abuse of opioids have become a growing concern worldwide, with devastating consequences for public health. While the immediate dangers of opioid overdose are well-documented, a silent and potentially lethal complication often lurks in the shadows—opioid-induced respiratory depression...

Find More

narcan-approval-for-opioid-use-disorder-treatment
How Decisive Will The OTC Approval of NARCAN Be In The Fight Against The Opioid Epidemic?

On March 29, 2023, the FDA made the landmark decision to approve Emergent BioSolutions’ NARCAN nasal spray for over-the-counter (OTC) and nonprescription use, making it the first naloxone product to be approved for use without a prescription. With about 80,000 fatal opioid overdoses every year, this could potent...

Find More